This Is A Custom Widget

This Sliding Bar can be switched on or off in theme options, and can take any widget you throw at it or even fill it with your custom HTML Code. Its perfect for grabbing the attention of your viewers. Choose between 1, 2, 3 or 4 columns, set the background color, widget divider color, activate transparency, a top border or fully disable it on desktop and mobile.

This Is A Custom Widget

This Sliding Bar can be switched on or off in theme options, and can take any widget you throw at it or even fill it with your custom HTML Code. Its perfect for grabbing the attention of your viewers. Choose between 1, 2, 3 or 4 columns, set the background color, widget divider color, activate transparency, a top border or fully disable it on desktop and mobile.

Parkinsons Disease

/Parkinsons Disease

NEW PARKINSON’S DRUG SAFINAMIDE, LAUNCHED IN THE UK

26 May 2016 This week commencing 23 May, international pharma company Zambon and its partner Newron Pharmaceuticals launched a new Parkinson’s drug called safinamide (trade name Xadago®) in the UK. The drug gained approval in the EU last December following a 2 year study in people with mid to advanced Parkinson's who were already taking [...]

Study Highlights importance of immune system in Parkinson’s

28 June 2016 Researchers in Canada have discovered that the genes affected in Parkinson's play an important role in protecting cells from attack by the body's own immune system. PINK1 and Parkin are the genes that are thought to keep the cell batteries, or mitochondria, healthy. The new findings were published in scientific journal Cell and they [...]

Dopamine-making neurons can be chemically controlled in animal model of Parkinson’s

The San Diego Union-Tribune - Stem cell-derived neurons transplanted into the brains of Parkinsons' patients may be controllable by drugs after transplantation, according to research performed in a mouse model of the disease. If the work can be translated to humans, it would allow doctors to fine-tune the transplanted neurons to the needs of individual [...]

Parkinson’s Disease

by Drs.Like Wu, Xiaojuan Wang, Bo Cheng, Susan Chu and Shengjie Liu Wu Medical Center, Bejing, China About PD Parkinson's disease (PD) is a degenerative disorder of the central nervous system, PD is more commonly seen in the elderly. With most cases occurring after the age of 60, the sickness rate after the age of 65 [...]

New technique can provide better cell transplants against Parkinson’s disease

Researchers at Lund University in Sweden have used a completely new preclinical technique and analysis of tissue from patients to show exactly what happens when certain patients with Parkinson's disease are restored as a result of nerve cell transplants. They have also identified what makes many of the transplant patients develop serious side effects in [...]

Strategies for Combating Cognitive Decline in PD

Maximizing Current and Developing Future Treatments for PD

Introductions & John Forsayeth, PhD: Why we get Parkinson’s disease

Transplanted nerve cells survive a quarter of a century in a Parkinson’s disease patient

In the late 1980s and over the 1990s, researchers at Lund University in Sweden pioneered the transplantation of new nerve cells into the brains of patients with Parkinson's disease. The outcomes proved for the first time that transplanted nerve cells can survive and function in the diseased human brain. Some patients showed marked improvement [...]